UNSPSC 51384525: Ibuprofen aluminum

This classification denotes a cyclooxygenase inhibitor with the molecular formula 2C13H17O2.Al.HO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D0YGZ1VO1B, chemically known as aluminium, hydroxybis(.alpha.-methyl-4-(2-methylpropyl)benzeneacetato-.kappa.o)-, but more generally known as ibuprofen aluminum, which bears US NIH Compound Identifier 16683040. European Medicines Agency schedules ibuprofen aluminum or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08098MIG.

Most nations, for tariff purposes, schedule ibuprofen aluminum under HS 29163990. SMILES: CC(C)CC1CCC(CC1)C(C)C(=O)[O-].CC(C)CC1CCC(CC1)C(C)C(=O)[O-].[OH-].[AL+3].

UNSPSC 51384525 Ibuprofen aluminum is a Commodity code that in practice sees minimal state and local procurement activity aligned with its nominal pharmaceutical scope. The single recent opportunity on record—Seminole County, Florida's IFB 60459723LAS—solicits Naloxone and Safe Drug Deactivation Systems, which fall outside the ibuprofen formulation category entirely and suggest a tagging mismatch rather than authentic market demand for the code's specified product. State and local governments do not currently appear to be purchasing ibuprofen aluminum preparations through formal competitive solicitations at a scale sufficient to support active business development under this code.

The recorded opportunity does not reflect the code's intended scope. Seminole County's IFB, posted June 30, 2026 with a response deadline of July 26, 2023, targets opioid-reversal and pharmaceutical waste management supplies—a category orthogonal to ibuprofen procurement. The absence of additional recent opportunities and the categorical mismatch of the single available record indicate that state and local procurement under UNSPSC 51384525 does not represent a material avenue for vendor engagement at this time.